Authors Popovic A, Tartare-Deckert S
Frontiers in oncology Sep 2022
[Transcription factor HES6, a key player in uveal melanoma].Authors Nucera L, Perrée E, Pujas P, Rouchon C, Wachich M, Selveswaran S, Arrighi N
Medecine sciences : M/S Sep 2022
[Is uveal melanoma similar to cutaneous melanoma?]Authors Ch Papasotiriou E, Ben Abdeljelil R, Benhammou I, Bertin L, Chadeuf E, Colve G, Arrighi N
Medecine sciences : M/S Sep 2022
[Analysis of primary uveal melanomas using single cell RNA sequencing].Authors Grandjean-Closson E, Heckmann C, Le Coz C, Louvet I, Neri M, Bertolotto C
Medecine sciences : M/S Sep 2022
Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis.Authors Heim M, Irondelle M, Duteil L, Cardot-Leccia N, Rocchi S, Passeron T, Tulic MK
Experimental dermatology Sep 2022
IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response.Authors Martinez-Turtos A, Paul R, Grima-Reyes M, Issaoui H, Krug A, Mhaidly R, Bossowski JP, Chiche J, Marchetti S, Verhoeyen E, Chevet E, Ricci JE
Oncoimmunology Sep 2022
Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial.Authors Rialland F, Grain A, Labopin M, Michel G, Gandemer V, Paillard C, Pochon C, Clement L, Brissot E, Jubert C, Sirvent A, Rohrlich PS, Plantaz D, Dalle JH, Mohty M
Bone marrow transplantation Aug 2022
Functional Impairment of Endothelial Colony Forming Cells (ECFC) in Patients with Severe Atherosclerotic Cardiovascular Disease (ASCVD).Authors Simoncini S, Toupance S, Labat C, Gautier S, Dumoulin C, Arnaud L, Stathopoulou MG, Visvikis-Siest S, Rossi PM, Benetos A, Dignat-George F, Sabatier F
International journal of molecular sciences Aug 2022
The Stress-Responsive microRNA-34a Alters Insulin Signaling and Actions in Adipocytes through Induction of the Tyrosine Phosphatase PTP1B.Authors Cornejo PJ, Vergoni B, Ohanna M, Angot B, Gonzalez T, Jager J, Tanti JF, Cormont M
Cells Aug 2022
Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.Authors Khatir W, Humbert O, Benzaquen J, Bontoux C, Neels J, Berland L, Rivera FAG, Allegra M, Salah M, Tanga V, Bordone O, Fayada J, Lespinet-Fabre V, Bohly D, Long-Mira E, Lassalle S, Vouret V, Brest P, Mograbi B, Maniel C, Otto J, Boutros J, Heeke S, Hofman V, Marquette CH, Hofman P, Ilié M
Clinical and translational medicine Aug 2022